Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep;86(3):s882-8.
doi: 10.1093/ajcn/86.3.882S.

Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice

Affiliations

Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice

Jin-Rong Zhou et al. Am J Clin Nutr. 2007 Sep.

Abstract

Background: The prevalence of metabolic syndrome is high and is increasing in parallel with increasing incidences of breast and prostate cancers. The combination of soy with tea was shown to have synergistic effects on preventing breast and prostate tumors, but the effects of soy and tea combinations on metabolic syndrome-related elements have not been investigated.

Objective: We aimed to determine the effects of soy and tea components, alone and in combination, on abdominal adipose mass and serum concentrations of adipokines, growth factors, and sex hormones in male and female mice.

Design: Male and female FVB/N mice were treated with soy, tea components, or both. Food intake and body weight were monitored weekly. At the end of the experiment, abdominal white adipose tissue was weighed, and serum concentrations of biomarkers were measured.

Results: Whole teas, but not the tea polyphenol extracts, significantly reduced abdominal white adipose tissue by 43-60% in female mice and by 65-70% in male mice. The combination of soy phytochemical concentrate and green tea reduced serum insulin-like growth factor-I concentrations in both male and female mice in a synergistic manner. The soy phytochemical concentrate and tea combinations reduced serum estrogen concentrations in female mice in a synergistic manner. Soy phytochemical concentrate and teas also significantly reduced serum leptin concentrations in both male and female mice and testosterone concentrations in male mice.

Conclusion: Further research is warranted to investigate whether soy and tea combinations may prevent breast or prostate cancer in a synergistic manner in part by alleviating metabolic disorders.

PubMed Disclaimer

Conflict of interest statement

None of the authors had any conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Effects of soy phytochemical concentrate (SPC) and tea combinations on serum concentrations of insulin, leptin, insulin-like growth factor-I (IGF-I), adiponectin, adiponectin corrected for white adipose tissue (WAT), and testosterone in male mice. C, control; BT, black tea; GT, green tea. Values are ± SEM, n = 12/group, and were analyzed by ANOVA followed by Tukey’s test. Within each panel, the value with a letter is significantly different from the control: aP < 0.05, bP < 0.005, cP < 0.0005.
FIGURE 2
FIGURE 2
Effects of soy phytochemical concentrate (SPC) and tea combinations on serum concentrations of insulin, leptin, insulin-like growth factor-I (IGF-I), adiponectin, adiponectin corrected for white adipose tissue (WAT), and estradiol (E2) in female mice. C, control; BT, black tea; GT, green tea. Values are ± SEM, n = 12/group, and were analyzed by ANOVA followed by Tukey’s test. Within each panel, the value with a letter is significantly different from the control: aP < 0.05, cP < 0.0005.

Similar articles

Cited by

References

    1. Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr. 1999;53:83–87. - PubMed
    1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–591. - PubMed
    1. Sinagra D, Amato C, Scarpilta AM, et al. Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci. 2002;6:55–59. - PubMed
    1. Okobia MN, Bunker CH, Zmuda JM, et al. Anthropometry and breast cancer risk in Nigerian women. Breast J. 2006;12:462–466. - PubMed
    1. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer. 2006;119:236–238. - PubMed

Publication types

MeSH terms